COMMUNIQUÉS West-GlobeNewswire
-
Personalized Keto Made Easy: How Ketoway Supports Consistent Results and Healthy Habits
17/03/2026 -
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
17/03/2026 -
Standard Process Launches SP Children’s® ProSynbiotic
17/03/2026 -
HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
17/03/2026 -
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
17/03/2026 -
Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors
17/03/2026 -
Microbot Medical® to Participate at the 38th Annual Roth Conference
17/03/2026 -
Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members
17/03/2026 -
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
17/03/2026 -
PatchMD Named the World’s #1 Vitamin Patch Brand in 2026 — And It’s Not Even Close
17/03/2026 -
Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference
17/03/2026 -
Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy
17/03/2026 -
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
17/03/2026 -
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
17/03/2026 -
Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
17/03/2026 -
ReFocus Eye Health Expands Presence Through Strategic Affiliation with Seven Partner Practices and Four Ambulatory Surgery Centers
17/03/2026 -
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
17/03/2026 -
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
17/03/2026 -
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
17/03/2026
Pages